Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Skyline Therapeutics is a fully integrated gene and cell therapy company dedicated to the discovery, development, and delivery of innovative therapies. Through the development of transformative therapies, we are committed to making a meaningful impact on the lives of patients with devastating diseases. The Skyline team’s capabilities span capsid discovery, vector engineering and design, in-vivo pharmacology, clinical develop...
Skyline Therapeutics is a fully integrated gene and cell therapy company dedicated to the discovery, development, and delivery of innovative therapies. Through the development of transformative therapies, we are committed to making a meaningful impact on the lives of patients with devastating diseases. The Skyline team’s capabilities span capsid discovery, vector engineering and design, in-vivo pharmacology, clinical development, analytical and process development, and CMC. Founded in 2019, Skyline Therapeutics is headquartered in China, with well-established research, development, and manufacturing capabilities in Shanghai and Hangzhou.

List your booth number for exhibitions, ask us